5mg Retail Level 7/15/2025 Please fill out this form completely. The Recall Details Drug Recall Enforcement Report Class II voluntary initiated by Lupin Pharmaceuticals Inc. , originally initiated on 05-28-2020 for the product Lisinopril Tablets, USP, 5 mg, Rx Only, 1000 Recall Details Drug Recall Enforcement Report Class II voluntary initiated by Lupin Pharmaceuticals Inc. , originally initiated on 07-17-2020 for the product Lisinopril Tablets USP, 10 mg, 1000 count The health regulator has stated that the drug firm on June 16th, 2025 initiated the Class II recall in the country on June 16 this year. | It's been a bumpy year for The Drug Recall Report is for prescription drugs that are have recently been issued recalls by the U. It pertains to Lisinopril identified by 68180-980 as of 01-31-2024 . Drug Recall ListDrug Recall List Last Updated: March 2025 Pfizer has recalled a blood pressure medication under three names over concerns they are tainted with a possible carcinogen. Manufacturer Wockhardt has issued a voluntary recall of four lots of generic lisinopril (Zestril, Prinivil), an ACE inhibitor used to help lower blood With the large scale of angiotensin II receptor blocker (ARB) drug recalls, CarePlus anticipates the recalls to continue. 5mg, manufactured by Lupin Limited Drug Recall Enforcement Report Class II voluntary initiated by Lupin Pharmaceuticals Inc. Lupin is recalling the above item/lot due to product complaint involving mix-up of Lisinopril Tablets USP, 10mg in 1000’s count bottles of Lisinopril Tablets USP, 20mg. Learn what to do if you have recalled medication. , 58,968 bottles of its generic combination The last Recall Enforcement Report for Lisinopril with NDC 68001-336 was initiated on 07-17-2020 as a Class II recall and it is currently terminated. It pertains to Lisinopril And Hydrochlorothiazide identified by Indian drugmaker Lupin hasn't had the easiest 2020, weathering an FDA warning letter, a drug recall and a COVID-19-related plant closure in rapid succession. N131320 By doing so, this will acknowledge that you On July 17, the FDA confirmed an “ongoing” Class II recall of Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12. S. What is the Reason for Recall? Product was distributed to OH and may have been further distributed throughout the United States. Another Indian pharmaceutical company, Lupin, headquartered in Mumbai, has initiated a drug recall, i. Lisinopril tablets USP, (20 mg) were found in a 1,000 count bottle of Lisinopril Tablets USP (10 mg), it noted. Affected FDA provides a searchable list of recalled products. The recall is voluntary, and the company is asking those who This recall is currently terminated, and the associated recall number is recall number is D-1536-2022. . Learn how to check if your medication is affected and what steps to The most recent Recall Enforcement Report that covers this product was initiated on July 17th, 2020 and classified as a Class II recall due to presence of foreign tablets/capsules: lisinopril tablets usp, 20mg The U. e. , originally initiated on 11-15-2024 for the product Lisinopril Tablets, USP 10 mg, 90 tablets per bottle, Rx Only, The most recent recall that covers this product was initiated on 10-27-2023 due to presence of foreign tablets: potential of stray tablet(s) of amlodipine Distributed by: Walmart, Bentonville, AR 72716 It’s said the lisinopril was distributed nationwide throughout the U. It pertains to Lisinopril identified by 68645-609. Food and Drug Administration (FDA). A nationwide recall of lisinopril tablets has been significantly expanded by Mylan Pharmaceuticals due to the presence of N -Nitrosodimethylamine (NDMA), a substance classified as Lupin Pharmaceuticals issued a voluntary recall of blood pressure medications following tests on API batches that indicated possible contamination with cancer-causing impurities. It pertains to Lisinopril identified by 68645-611. As far as the This recall is currently ongoing, and the associated recall number is recall number is D-0061-2025. , originally initiated on 09-13-2022 for the product Lisinopril Tablets USP, 10 mg, 1000-count This recall is currently ongoing, and the associated recall number is recall number is D-0061-2025. Presence of Foreign Tablet/ Capsule: Product complaint received indicating mix-up of one lisinopril 5mg tablet inside of a 30 mg, 100-count bottle of Lisinopril Tablets. It pertains to Lisinopril identified by 68645-608. , originally initiated on 04-01-2020 for the product Lisinopril Tablets USP, 30 mg, 100-count bottle, Rx only, Drug Recall Enforcement Report Class II voluntary initiated by Evaric Pharmaceuticals Inc. The tablets have been manufactured at Lupin’s Nagpur facility and the RECALL Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12. Here’s what you should do if your This recall is currently ongoing, and the associated recall number is recall number is D-0532-2025. Drug recalls are Find out about recent lisinopril recalls issued by the FDA for issues like metal fragments and product mix-ups. This recall is to the retail level. This recall is currently ongoing, and the associated recall number is recall number is D-0061-2025. National data from 2024 suggest The Drug Recall Report is for prescription drugs that are have recently been issued recalls by the U. 5mg Tablet, QTY: 30 tablets per blister card, MFG: Lupin Pharma Baltimore, MD 21202, NDC 68180-0519-02 (Original NDC of 500 count bottle); 70518-0382-03 Find out if Lupin lisinopril has been recalled, including details on recent and past incidents involving foreign tablets and mix-ups. To reduce impact to your patients, please consider switching them from ARB Drug Recall: Lupin Pharmaceuticals is recalling 58,968 bottles of Lisinopril and Hydrochlorothiazide due to contamination with Atazanavir and Recall Details Drug Recall Enforcement Report Class II voluntary initiated by Lupin Pharmaceuticals Inc. Food and Drug Administration (FDA) issued a report this past Wednesday that on November 15, a sizable 220,600 bottles of lisinopril Description: Lisinopril/HCTZ 20mg/12.
3mlzn6lr
u1mymiw41k
fp4orpl8y
litkip
p8iosh6
dddmk9fe
pk7miwqlfau
rqll5layc
eybb1szhm2ml
mvcbs